Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$448K Buy
4,939
+539
+12% +$49.2K 0.03% 165
2026
Q1
$452K Buy
4,400
+186
+4% +$21K 0.03% 151
2025
Q4
$528K Sell
4,214
-226
-5% -$28.8K 0.04% 134
2025
Q3
$595K Buy
4,440
+308
+7% +$40.4K 0.04% 126
2025
Q2
$562K Sell
4,132
-6
-0.1% -$791 0.05% 128
2025
Q1
$549K Buy
4,138
+14
+0.3% +$1.78K 0.05% 126
2024
Q4
$466K Hold
4,124
0.04% 137
2024
Q3
$470K Sell
4,124
-32
-0.8% -$3.51K 0.04% 137
2024
Q2
$432K Buy
+4,156
New +$441K 0.04% 145

Other funds holding ABT

Hardy Reed's ABT Position: Q2 2026 in Review

Hardy Reed increased its Abbott (ABT) stake by 12% in Q2 2026, buying an estimated $49.2K and bringing the position to 4,939 shares worth $448K. The position accounts for 0.03% of the portfolio, ranked #165.

Hardy Reed first reported a position in ABT in Q2 2024 and has held it in 9 quarters since. The position peaked at $595K in Q3 2025. 2,975 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Hardy Reed held 4,939 shares of Abbott worth $448K as of Q2 2026.
  • Hardy Reed bought 539 Abbott shares in Q2 2026, an estimated $49.2K.
  • Abbott made up 0.03% of Hardy Reed's portfolio in Q2 2026, its #165 holding.
  • Hardy Reed first reported a position in Abbott in Q2 2024 and has held it in 9 quarters since.
  • Hardy Reed's Abbott position peaked at $595K in Q3 2025.
  • 2,975 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Hardy Reed's 13F filing for Q2 2026, filed 3 Aug 2026.